The Impact of the COVID-19 Pandemic in Canadians with Cardiovascular Disease

Author

Reviewer

Share Article

Published on : June 02, 2022

(1)  (463)  

What has been the impact of COVID-19 on Canadians with cardiovascular disease?

 

Author Reviewer

Shaun Goodman, MD, MSc

Co-Director, Canadian VIGOUR Centre, University of Alberta

Associate Head, Division of Cardiology, St. Michael's Hospital 

Toronto, ON

Milan Gupta, MD, FRCPC, FCCS, CPC(HC)

Assistant Professor, Department of Medicine, University of Toronto
Medical Director, Canadian Collaborative Research Network
Brampton, ON 

 

 

The coronavirus disease 2019 (COVID-19) pandemic has impacted cardiovascular (CV) outcomes and care globally, although to date, there is limited information describing the Canadian experience. In Sweden, which has a publicly supported and widely accessible healthcare system like Canada, COVID-19 has been identified as a risk factor for the subsequent occurrence of acute myocardial infarction (MI) and ischemic stroke, particularly in the first 2 weeks post-infection. The Swedish observations are consistent with previous studies in the pre-COVID-19 era where a transient increase in the risk of MI and stroke has been observed in association with influenza, pneumonia, acute bronchitis, and other chest infections. Thus, in addition to acute CV complications of COVID-19 itself—like myocarditis, pericarditis, decompensated heart failure (HF), and pulmonary embolism—CV implications of the pandemic will likely extend beyond direct, infection-related CV damage.

In England and the United States, several studies have also described significant early decreases in CV testing (e.g., exercise stress tests, echocardiography, nuclear imaging, coronary artery calcium scoring, coronary computed tomographic angiography, percutaneous coronary intervention, coronary artery bypass graft surgery, and transcatheter aortic valve replacement), with disproportionate impacts on older, female, and non-white patients.  While in some jurisdictions it appears that these reductions were only temporary, concern remains that the public health response to the pandemic—meant to mitigate morbidity and mortality from acute COVID-19—may have the unintended consequence of increasing CV risk in much larger proportions of the general population.

We therefore undertook an observational study aimed at characterizing trends in the use of important biomarkers of atherosclerotic cardiovascular disease (ASCVD) risk—troponin and low-density lipoprotein cholesterol (LDL-C), the use of invasive cardiac procedures, and major adverse cardiovascular events (MACE) prior to and during the COVID-19 pandemic in the province of Alberta.

 

Impact on ASCVD Testing

copyright © 2023 MDLearn
Any views expressed above are the author's own and do not necessarily reflect the views of MDLearn.

Continue learning with MDRead

Published on May 22, 2023

Chronic Urticaria

Chronic Urticaria: That Unrelenting and Nagging Itch &nb...

Published on April 25, 2023

Allergic Rhinitis

The Birds and Bees and Allergies: The Forgotten Burden of...

Published on April 06, 2023

PCSK9 inhibitors: For Which Patient and When?

PCSK9 inhibitors: For Which Patient and When?...

Published on February 10, 2023

Osteoporosis Management in Primary Care – Sinking Your Teeth Into ONJ – Debunking Myths and Unde...

Sinking Your Teeth Into ONJ – Debunking Myths and Unde...

Published on January 25, 2023

Osteoporosis Management in Primary Care – Helping patients understand the risks and benefits of os...

Denosumab 101 Safety, Tolerability and Calcium Monitoring&...

Published on January 13, 2023

Osteoporosis Management in Primary Care – Identifying when to use anabolic therapies

Osteoporosis Management in Primary Care – Anabolic The...

Published on December 10, 2022

Dyslipidemia Management in Primary Care

Dyslipidemia Management in Primary Care   This blog c...

Published on December 06, 2022

Dietary Supplements

What advice do I give to my patients who use dietary supplem...

Published on October 13, 2022

Shingles Vaccination Keeping Pandora’s Box Closed

What has changed in terms of Herpes Zoster guidance and why...

Published on October 13, 2022

SOME CALL IT SLEEP

What’s New in Insomnia Management and Treatment &ld...

Published on September 16, 2022

When Plan B is Plan A… Meningitis B Vaccination

Meningitis B vaccination - a call to action. Why should Men...

Published on May 06, 2022

Hypertension- A Salty Topic

Why are we still talking about hypertension?   &nbs...

Published on March 31, 2022

I’m ready to use natriuretic peptide testing in my patients with dyspnea to diagnose heart failure...

How to incorporate BNP testing into primary care....

Back